24 In this study focused on 14 Asia Pacific countries, we observed an increasing trend of total biologics consumption and expenditure over the last decade with an additional increased trend of biologics focused on other targets.
← all excerpts
Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020.
1
—
—